Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 55Pancreatic Neoplasms 14Colorectal Neoplasms 6Neoplasm Metastasis 5Esophageal Squamous Cell Carcinoma 5Esophageal Neoplasms 4Biliary Tract Neoplasms 4Advanced Pancreatic Cancer 3Stage IV Gastric Cancer With Metastasis 2Recurrence 2Rectal Neoplasms 2Locally Advanced Pancreatic Cancer 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced Gastric Cancer 2mCRC 1Surgically-Created Resection Cavity 1Radiation Injuries 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Non-small Cell Lung Cancer Stage â…¡ 1Nasopharyngeal Carcinoma 1NSCLC 1Metastatic Gastric Adenocarcinoma 1Lung Neoplasms 1HER2-positive 1HER-2 Negatived Gastric Cancer 1Gastric Cancer With Positive Exfoliative Cancer Cells 1

Interventions

Docetaxel 2apatinib 1Taxes 1S 1 (combination) 1Radiotherapy 1Paclitaxel 1Injections 1Drug Evaluation 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastric Adenocarcinoma × S 1 (combination) × Clear all
NCT01283217 2013-06-04

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

Yonsei University

Phase 3 Unknown
166 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡